Clinical trial
A Double-Blind, Placebo-Controlled, Randomized, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered JNJ-75220795 in Japanese Participants
NCT05039710 is registered in ClinicalTrials.gov with Janssen Pharmaceutical K.K. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Placebo-Controlled, Randomized, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered JNJ-75220795 in Japanese Participants
- Lead sponsor
- Janssen Pharmaceutical K.K.
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- November 8, 2021
- Completion date
- February 17, 2023
- Enrollment
- 9 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.